Evidence map›Paper›PMID 20036201›Full record

ArticleJournal of chromatography. B, Analytical technologies in the biomedical and life sciences2010

Metabolomic analysis of uremic toxins by liquid chromatography/electrospray ionization-tandem mass spectrometry.

Kaori Kikuchi, Yoshiharu Itoh, Ryoko Tateoka, Atsuko Ezawa, Kenjiro Murakami, Toshimitsu Niwa

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. A metabolic biomarker panel of restless legs syndrome in peritoneal dialysis patients.Metabolomics : Official journal of the Metabolomic Society · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. How Omics Data Can Be Used in Nephrology.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2018
    Review
  13. A Systems-Level View of Renal Metabolomics.Seminars in nephrology · 2018
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Approaches to uremia.Journal of the American Society of Nephrology : JASN · 2014
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kaori KikuchiBiomedical Research Laboratories, Kureha Corporation, Tokyo, Japan.
Yoshiharu Itoh
Ryoko Tateoka
Atsuko Ezawa
Kenjiro Murakami
Toshimitsu Niwa
Kureha (Japan) · JPNagoya University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We applied the metabolomic analysis of comprehensive small-molecular metabolites using liquid chromatography/electrospray ionization-tandem mass spectrometry (LC/ESI-MS/MS) and principal component analysis to identify uremic toxins accumulated in the serum of chronic renal failure (CRF) rats. CRF rats were produced by 5/6-nephrectomy. Indoxyl sulfate was demonstrated to be the first principal serum metabolite which differentiates CRF from normal, followed by phenyl sulfate, hippuric acid and p-cresyl sulfate. Then, we measured the serum levels of indoxyl sulfate, phenyl sulfate, hippuric acid and p-cresyl sulfate by the selected reaction monitoring (SRM) of LC/ESI-MS/MS, and demonstrated that these serum levels were markedly increased in CRF rats as compared with normal rats. As creatinine clearance decreased, the serum levels of the metabolites increased.

Indexed as

AnimalsChromatography, LiquidCresolsDisease Models, AnimalHippuratesHumansIndicanKidneyKidney Failure, ChronicMaleMetabolomicsRatsRats, Sprague-DawleySpectrometry, Mass, Electrospray IonizationSulfuric Acid EstersToxins, Biological4-cresol sulfateCresolsHippurateshippuric acidIndicanSulfuric Acid EstersToxins, Biological

Identifiers

PMID20036201
OpenAlexW2043026251

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.